Clinical Trial Update: A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3 [Phase 2]

View source ↗

Summary

Phase 2 multicenter, double-blind study comparing zidovudine alone versus zidovudine plus acyclovir in HIV patients with CD4+ counts <200 cells/mm3; study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• ACYCLOVIR (Acyclovir)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED